Literature DB >> 21350711

Influence of CXCR4/SDF-1 axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells.

Lin Wang1, Cui-Ling Li, Lei Wang, Wen-Bin Yu, Hai-Peng Yin, Guang-Yong Zhang, Li-Feng Zhang, Sheng Li, San-Yuan Hu.   

Abstract

AIM: To study the influence of CXCR4/stromal cell-derived factor-1 (SDF-1) axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells and its underlying mechanisms.
METHODS: Effect of SDF-1 on E-cadherin/β-catenin expression was detected by immunocytochemistry. E-cadherin and β-catenin mRNA expression levels were measured by reverse transcriptase-polymerase chain reaction. SDF-1-induced phosphorylation of phosphatidylinositol 3-kinase (PI3K)/AKT and β-catenin was detected by Western blotting.
RESULTS: The E-cadherin and β-catenin mRNA expression levels in HT29 cells were lower 48 h after incubated with SDF-1 at the concentrations of 20 and 40 ng/mL (P<0.05). SDF-1-induced significant phosphorylation of PI3K/AKT and β-catenin. AMD3100 and LY294002 inhibited the phosphorylation of PI3K/AKT and β-catenin.
CONCLUSION: SDF-1 down-regulates the E-cadherin/β-catenin complex expression in HT29 cells by decreasing mRNA synthesis and increasing β-catenin phosphorylation.

Entities:  

Keywords:  CXCR4; Colon cancer; E-cadherin; Phosphatidylinositol 3-kinase/AKT; Stromal cell-derived factor-1; β-catenin

Mesh:

Substances:

Year:  2011        PMID: 21350711      PMCID: PMC3040334          DOI: 10.3748/wjg.v17.i5.625

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  [Effects of K-ras gene mutation on colon cancer cell line Caco-2 metastasis by regulating E-cadherin/beta-catenin/p120 protein complex formation and RhoA protein activity].

Authors:  Jing-nan Li; Xiao Li; Jia-ming Qian; Xin-qing Lu; Hong Yang
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  2010-02

Review 2.  Changes in regulation of cell-cell adhesion during tumor transformation.

Authors:  N A Gloushankova
Journal:  Biochemistry (Mosc)       Date:  2008-07       Impact factor: 2.487

3.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

4.  Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.

Authors:  Jennifer L Yori; Emhonta Johnson; Guangjin Zhou; Mukesh K Jain; Ruth A Keri
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

5.  Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.

Authors:  Wenjing Zhang; Bo Jiang; Zheng Guo; Claude Sardet; Bing Zou; Colin S C Lam; Jianming Li; Mingliang He; Hui-Yao Lan; Roberta Pang; I F N Hung; V P Y Tan; Jide Wang; Benjamin C Y Wong
Journal:  Carcinogenesis       Date:  2010-05-11       Impact factor: 4.944

6.  Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.

Authors:  Ombretta Salvucci; Lei Yao; Sabrina Villalba; Agatha Sajewicz; Stefania Pittaluga; Giovanna Tosato
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

7.  ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.

Authors:  E Sánchez-Tilló; A Lázaro; R Torrent; M Cuatrecasas; E C Vaquero; A Castells; P Engel; A Postigo
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

8.  Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.

Authors:  Massimo Pancione; Nicola Forte; Alessandra Fucci; Lina Sabatino; Antonio Febbraro; Arturo Di Blasi; Bruno Daniele; Domenico Parente; Vittorio Colantuoni
Journal:  Hum Pathol       Date:  2010-02-04       Impact factor: 3.466

9.  Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.

Authors:  Ha Na Choi; Kyung Ryoul Kim; Ji Hyun Lee; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Si Eun Hwang; Hee Chul Yu; Woo Sung Moon
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  8 in total

1.  Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

Authors:  Zeng Li; Nan Li; Minghua Wu; Xiayu Li; Zhaohui Luo; Xiaoyan Wang
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

2.  CXCR4 Expression and Treatment with SDF-1α or Plerixafor Modulate Proliferation and Chemosensitivity of Colon Cancer Cells.

Authors:  Doreen Heckmann; Patrick Maier; Stephanie Laufs; Frederik Wenz; W Jens Zeller; Stefan Fruehauf; Heike Allgayer
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

3.  SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway.

Authors:  Yao Lu; Bin Hu; Guo-Feng Guan; Jie Chen; Chun-qiu Wang; Qiong Ma; Yan-Hua Wen; Xiu-Chun Qiu; Xiao-ping Zhang; Yong Zhou
Journal:  Med Oncol       Date:  2015-05-31       Impact factor: 3.064

4.  Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.

Authors:  Kyoko Yamaguchi; Tomoyasu Yoshihiro; Hiroshi Ariyama; Mamoru Ito; Michitaka Nakano; Yuichiro Semba; Jumpei Nogami; Kenji Tsuchihashi; Takuji Yamauchi; Shohei Ueno; Taichi Isobe; Koji Shindo; Taiki Moriyama; Kenoki Ohuchida; Masafumi Nakamura; Yoshihiro Nagao; Tetsuo Ikeda; Makoto Hashizume; Hiroyuki Konomi; Takehiro Torisu; Takanari Kitazono; Tomohiro Kanayama; Hiroyuki Tomita; Yoshinao Oda; Hitoshi Kusaba; Takahiro Maeda; Koichi Akashi; Eishi Baba
Journal:  Gastric Cancer       Date:  2022-06-04       Impact factor: 7.701

5.  CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers.

Authors:  Nicolas Barry Delongchamps; Frédéric Beuvon; Jacques R R Mathieu; Stéphanie Delmas; Isabelle Metzger; Hervé Prats; Florence Cabon
Journal:  World J Urol       Date:  2014-04-19       Impact factor: 4.226

6.  LncCDH5-3:3 Regulates Apoptosis, Proliferation, and Aggressiveness in Human Lung Cancer Cells.

Authors:  Konrad Kwaśniak; Justyna Czarnik-Kwaśniak; Khrystyna Malysheva; Katarzyna Pogoda; Olexandr Korchynskyi; Paweł Rybojad; Bożenna Karczmarek-Borowska; Jacek Tabarkiewicz
Journal:  Cells       Date:  2022-01-23       Impact factor: 6.600

Review 7.  Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7.

Authors:  Aïssata Aimée Goïta; Dominique Guenot
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

8.  Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.

Authors:  Barbara Mognetti; Giuseppe La Montagna; Maria Giulia Perrelli; Pasquale Pagliaro; Claudia Penna
Journal:  J Cell Mol Med       Date:  2013-01-10       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.